Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease

J Clin Gastroenterol. 2019 May/Jun;53(5):395-397. doi: 10.1097/MCG.0000000000000952.

Authors

Joany E Kreijne^{1

2}, Janine van der Giessen^{1

2}, Auke P Verhaar^{1

2}, Maikel P Peppelenbosch^{1

2}, Annemarie C de Vries^{1

2}, C Janneke van der Woude^{1

2}, Gwenny M Fuhler^{1

2}

Affiliations

¹ Erasmus MC, University Medical Center Rotterdam.
² Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.

PMID: 29256991
DOI: 10.1097/MCG.0000000000000952

No abstract available

Publication types

Comment

MeSH terms

Biomarkers
Feces
Humans
Inflammatory Bowel Diseases*
Leukocyte L1 Antigen Complex
Lipocalin-2
Matrix Metalloproteinase 9*

Substances

Biomarkers
Leukocyte L1 Antigen Complex
Lipocalin-2
Matrix Metalloproteinase 9